Sunshine Biopharma Receives Canadian Approval to Launch Generic Hypertension Drug Enalapril
The drug is a generic version of the well-known brand Vasotec and will be available in 2.5mg, 5mg, 10mg, and 20mg tablet strengths. Sunshine Biopharma plans to distribute it in Canada through its wholly-owned subsidiary, Nora Pharma Inc., with the first products expected to arrive at retail pharmacies by the end of 2026.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Silver prices pulled back to $44.896, touching a nearly 365-day low.
-
2
Gold fell 3.23% from its previous close, currently trading at $3,722.69
-
3
Gold prices pulled back to $3,722.69, hitting a nearly 365-day low.
-
4
Silver is down 4.91% from its previous close, currently trading at $44.896
-
5
JPMorgan Chase: ConvaTec Group’s earnings update is expected to dispel market concerns over achieving its 2026 guidance
-
6
WTI crude oil fell 2.61% from its previous close, currently trading at $83.139.
-
7
White House: Trump Announces Over $17 Billion in Commercial Deals and Strategic Investments During Philippines Visit and ASEAN Summit
-
8
CoinDesk: Crypto Basis Trade Yields Near Treasuries, Talos Report Says
-
9
Bloomberg: Indian Tax Officials Considering Proposal to Raise Stock Derivatives Tax and Lower Stock Transaction Tax
-
10
Deltaone: Target Q3 Adjusted EPS $2.65, Raises Full-Year Guidance
Markets Today
Recommended Reading


